Published in Clin Cancer Res on September 01, 2000
The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patients. Br J Cancer (2001) 0.96
Efficacy of novel P-glycoprotein inhibitors to increase the oral uptake of paclitaxel in mice. Invest New Drugs (2004) 0.89
Population pharmacokinetics of orally administered paclitaxel formulated in Cremophor EL. Br J Clin Pharmacol (2005) 0.87
A phase I study of DHP107, a mucoadhesive lipid form of oral paclitaxel, in patients with advanced solid tumors: crossover comparisons with intravenous paclitaxel. Invest New Drugs (2012) 0.86
Oral bioavailability of a novel paclitaxel formulation (Genetaxyl) administered with cyclosporin A in cancer patients. Anticancer Drugs (2008) 0.82
Metronomic oral paclitaxel shows anti-tumor effects in an orthotopic mouse model of ovarian cancer. J Gynecol Oncol (2014) 0.80
Metabolism and excretion of novel pulmonary-targeting docetaxel liposome in rabbits. Korean J Physiol Pharmacol (2016) 0.75
Subcutaneous administration of paclitaxel in dogs with cancer: A preliminary study. Can Vet J (2015) 0.75
The sentinel node in breast cancer--a multicenter validation study. N Engl J Med (1998) 8.48
Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet (1998) 7.70
Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc Natl Acad Sci U S A (1994) 6.96
Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies. J Clin Oncol (2001) 5.17
Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Gastroenterology (2001) 3.85
Does anaesthesia cause postoperative cognitive dysfunction? A randomised study of regional versus general anaesthesia in 438 elderly patients. Acta Anaesthesiol Scand (2003) 3.79
The evolution of mutation rates: separating causes from consequences. Bioessays (2000) 3.48
The rapamycin-sensitive signal transduction pathway as a target for cancer therapy. Oncogene (2000) 3.40
pHG165: a pBR322 copy number derivative of pUC8 for cloning and expression. Plasmid (1986) 3.15
Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Intern Med (1989) 2.81
Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods. Gene Ther (2002) 2.59
Characterization of somatostatin transactivating factor-1, a novel homeobox factor that stimulates somatostatin expression in pancreatic islet cells. Mol Endocrinol (1993) 2.57
Vertical strabismus after cataract surgery. Ophthalmology (1996) 2.56
OATP1B1 polymorphism as a determinant of erythromycin disposition. Clin Pharmacol Ther (2012) 2.43
A let-7 microRNA-binding site polymorphism in 3'-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy. Ann Oncol (2010) 2.39
Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules. Br J Cancer (2003) 2.38
Risk prediction of prevalent diabetes in a Swiss population using a weighted genetic score--the CoLaus Study. Diabetologia (2009) 2.32
A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas. Br J Cancer (2006) 2.23
Impact of the media and the internet on oncology: survey of cancer patients and oncologists in Canada. J Clin Oncol (2001) 2.23
Cytotoxic effects of topotecan combined with various anticancer agents in human cancer cell lines. J Natl Cancer Inst (1996) 2.21
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. Ann Surg Oncol (2006) 2.13
Quantitation of epidermal nerves in diabetic neuropathy. Neurology (1996) 2.12
Platelet-tumor-cell interactions in mice. The role of platelets in the spread of malignant disease. Int J Cancer (1973) 2.05
Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer. J Clin Oncol (2001) 2.03
Successful re-treatment with taxol after major hypersensitivity reactions. J Clin Oncol (1993) 2.00
Differences in somatic perception in female patients with irritable bowel syndrome with and without fibromyalgia. Pain (2000) 1.97
Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation. Pain (1999) 1.90
The current status of camptothecin analogues as antitumor agents. J Natl Cancer Inst (1993) 1.84
Intradermal injection of capsaicin in humans produces degeneration and subsequent reinnervation of epidermal nerve fibers: correlation with sensory function. J Neurosci (1998) 1.82
Maternal bisphenol-A levels at delivery: a looming problem? J Perinatol (2008) 1.78
A randomised controlled study of close monitoring of vulnerable psychiatric patients. Lancet (1995) 1.76
A consensus amino-acid sequence repeat in Torpedo and mammalian Ca2+-dependent membrane-binding proteins. Nature (1986) 1.76
Mutant strains of Escherichia coli K12 that use D-amino acids. Proc Natl Acad Sci U S A (1971) 1.75
The pancreatic islet factor STF-1 binds cooperatively with Pbx to a regulatory element in the somatostatin promoter: importance of the FPWMK motif and of the homeodomain. Mol Cell Biol (1995) 1.71
Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancer. Clin Cancer Res (1999) 1.64
Listeners as co-narrators. J Pers Soc Psychol (2000) 1.64
A data processing system for hospital bacteriology. J Clin Pathol (1970) 1.63
A pharmacodynamic study of sorafenib in patients with relapsed and refractory acute leukemias. Leukemia (2010) 1.61
Spectroscopic diagnosis of bladder cancer with elastic light scattering. Lasers Surg Med (1995) 1.60
Antibiotic resistance--what can we do? Nat Med (1998) 1.59
Early intervention in psychiatric emergencies: a controlled clinical trial. Lancet (1992) 1.59
Stabilization of human immunodeficiency virus type 1 envelope glycoprotein trimers by disulfide bonds introduced into the gp41 glycoprotein ectodomain. J Virol (1998) 1.58
Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies. Ann Neurol (1994) 1.57
Phase I and pharmacologic study of the tyrosine kinase inhibitor SU101 in patients with advanced solid tumors. J Clin Oncol (1999) 1.56
Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial. Cancer Res (2000) 1.55
The story of the European Randomized Study of Screening for Prostate Cancer. BJU Int (2003) 1.55
Outcomes after seizure recurrence in people with well-controlled epilepsy and the factors that influence it. The MRC Antiepileptic Drug Withdrawal Group. Epilepsia (1996) 1.54
A comparative evaluation of conventional and pretargeted radioimmunotherapy of CD20-expressing lymphoma xenografts. Blood (2001) 1.52
Cytotoxic geranyl stilbenes from Macaranga schweinfurthii. J Nat Prod (1998) 1.50
In search of susceptibility genes for type 2 diabetes in West Africa: the design and results of the first phase of the AADM study. Ann Epidemiol (2001) 1.49
Particle size distribution analysis for the rapid detection of microbial infection of urine. J Clin Pathol (1979) 1.49
Molecular cloning and expression of human UDP-d-Xylose:proteoglycan core protein beta-d-xylosyltransferase and its first isoform XT-II. J Mol Biol (2000) 1.49
Intravenous azathioprine in severe ulcerative colitis: a pilot study. Am J Gastroenterol (2000) 1.46
TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease. Eur J Immunol (1993) 1.44
Localization of regional lymph nodes in melanomas of the head and neck. Arch Otolaryngol Head Neck Surg (1998) 1.43
Hormonal regulation of an islet-specific enhancer in the pancreatic homeobox gene STF-1. Mol Cell Biol (1997) 1.43
Supercoil sequencing using unpurified templates produced by rapid boiling. Biotechniques (1988) 1.43
A phase II "window" study of topotecan in untreated patients with high risk adult acute lymphoblastic leukemia. Clin Cancer Res (1998) 1.42
Cognitive dysfunction after minor surgery in the elderly. Acta Anaesthesiol Scand (2003) 1.42
Use of bacterial luciferase to establish a promoter probe vehicle capable of nondestructive real-time analysis of gene expression in Bacillus spp. J Bacteriol (1987) 1.42
Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study. Leukemia (2010) 1.42
Vinblastine and erythromycin: an unrecognized serious drug interaction. Cancer Chemother Pharmacol (1995) 1.41
Establishing the severity of personality disorder. Am J Psychiatry (1996) 1.40
Clinical and pharmacologic reappraisal of dichloromethotrexate. J Natl Cancer Inst (1988) 1.40
Hair transplantation in advanced male pattern alopecia. The role of incisional slit grafting. J Dermatol Surg Oncol (1991) 1.40
Increasing productivity and reducing errors through usability analysis: a case study and recommendations. Proc AMIA Symp (2000) 1.40
Bayesian analysis of pentaquark signals from CLAS data. Phys Rev Lett (2008) 1.39
Profile of disability in elderly people: estimates from a longitudinal population study. BMJ (1999) 1.38
The transcription of bacterial luminescence is regulated by sigma 32. J Biolumin Chemilumin (1989) 1.38
Outcome of panic disorder. Br J Psychiatry (1997) 1.38
Tissue transglutaminase in normal and abnormal wound healing: review article. Amino Acids (2004) 1.38
Measurement of two- and three-nucleon short-range correlation probabilities in nuclei. Phys Rev Lett (2006) 1.37
Randomised controlled trial of two models of care for discharged psychiatric patients. BMJ (1998) 1.37
Clinical trials of antibacterial agents: a practical guide to design and analysis. Statisticians in the Pharmaceutical Industry Working Party. J Antimicrob Chemother (1998) 1.37
Expression of the immunoglobulin VH gene 51p1 is proportional to its germline gene copy number. J Clin Invest (1996) 1.35
A phase I dose escalation and bioavailability study of oral sodium phenylbutyrate in patients with refractory solid tumor malignancies. Clin Cancer Res (2001) 1.34
Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion. J Clin Oncol (1993) 1.32
Color Doppler, power Doppler and B-flow ultrasound in the assessment of ICA stenosis: Comparison with 64-MD-CT angiography. Eur Radiol (2006) 1.30
Effect of vitamin D supplementation on testosterone levels in men. Horm Metab Res (2010) 1.30
Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependence. J Clin Oncol (1996) 1.28
Sexual assault and alcohol abuse: a comparison of lesbians and heterosexual women. J Subst Abuse (2001) 1.27
Synthesis and degradation of lac mRNA in E. coli depleted of 30S ribosomal subunits. Mol Gen Genet (1979) 1.27
Characterisation of the lung toxicity of the cell cycle inhibitor temsirolimus. Eur J Cancer (2006) 1.26
The C. elegans sex-determining gene fem-2 encodes a putative protein phosphatase. Mol Biol Cell (1995) 1.26
Axonemal tubulin polyglycylation probed with two monoclonal antibodies: widespread evolutionary distribution, appearance during spermatozoan maturation and possible function in motility. J Cell Sci (1996) 1.24
Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer. Br J Cancer (2006) 1.24
Tumour gene expression predicts response to cetuximab in patients with KRAS wild-type metastatic colorectal cancer. Br J Cancer (2011) 1.24
European randomized study of screening for prostate cancer. Progress report of Antwerp and Rotterdam pilot studies. Cancer (1995) 1.24
The teacher's role in facilitating memory and study strategy development in the elementary school classroom. Child Dev (1992) 1.23
Sequence and properties of operator mutations in the bio operon of Escherichia coli. Gene (1981) 1.23
Prepulse inhibition in psychiatric disorders--apart from schizophrenia. J Psychiatr Res (2013) 1.22
Detection of beta lactamase activity of Haemophilus influenzae. J Clin Pathol (1977) 1.21
Polymorphisms in the xylosyltransferase genes cause higher serum XT-I activity in patients with pseudoxanthoma elasticum (PXE) and are involved in a severe disease course. J Med Genet (2006) 1.20
Requirement for TAF(II)250 acetyltransferase activity in cell cycle progression. Mol Cell Biol (2000) 1.19
Role of D-tryptophan oxidase in D-tryptophan utilization by Escherichia coli. J Bacteriol (1976) 1.19
Autonomous differentiation in the mouse myogenic cell line, C2, involves a mutual positive control between insulin-like growth factor II and MyoD, operating as early as at the myoblast stage. J Cell Sci (1996) 1.19